HGH FRAGMENT 176-191 5 mg (AOD 9604)

HGH Fragment 176-191 5 mg (AOD 9604) reagent - characteristics

HGH Fragment 176-191 5 mg (AOD 9604) is a synthetic research peptide included in the C-terminal fragment group of human growth hormone. The molecule corresponds to an amino acid sequence comprising positions 176-191 in the structure of hGH and is described in the literature as a fragment associated with the lipolytic domain of growth hormone. In experimental studies HGH Fragment 176-191 5 mg is primarily being analysed as a short peptide of importance in metabolic models, particularly in relation to the regulation of adipose tissue, lipid metabolism and processes related to energy expenditure.

In the scientific literature, the peptide HGH Fragment 176-191 5 mg, also referred to as AOD 9604 is described primarily in terms of mechanisms related to the lipolysis i anti-lipogenic effect. Preclinical studies indicated that synthetic fragments corresponding to this domain could increase fat oxidation, affect adipocyte metabolism and reduce lipid deposition in models of obesity. The particular research interest of this molecule stems from the observation that this fragment was analysed as a peptide that retains selected metabolic properties associated with hGH, but without the full profile of action inherent in the whole growth hormone molecule.

The relationship between AOD9604 activity and adrenergic pathways and energy metabolism also remains an important area of scientific interest. It has been described in publications that an analogue of this domain, AOD9604, can increase lipolytic sensitivity and affect the expression of receptors beta-3 adrenergic in adipose tissue, and increase fat oxidation and energy expenditure in animal models. It is the combination of studies on lipolysis, fat oxidation and regulation of the expression of metabolism-related receptors that makes the HGH Fragment 176-191 5 mg remains an interesting reagent in analyses of adipocyte physiology and energy metabolism.

See also Melanotan II research peptide 10 mg

From a scientific characterisation perspective, the following are among the main research strengths HGH Fragment 176-191 5 mg (AOD 9604) include its well-defined structural origin, small molecule size and strong establishment in the experimental literature on lipid metabolism. At the same time, the available publications mainly concern preclinical models and metabolic studies on the analogue of the AOD9604, therefore interpretation of the results should take into account the experimental nature of this molecule and the fact that the scope of modern, high-quality clinical data is limited.

Scientific sources:

1. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism ... - paper on the effects of the lipolytic fragment of hGH on body weight, lipolysis and beta-3 adrenergic receptor expression in models of obesity.
2. Effects of oral administration of a synthetic fragment of human growth hormone... - publication describing the lipolytic and anti-lipogenic effects of a synthetic hGH fragment in adipose tissue.
3. Increase of fat oxidation and weight loss in obese mice produced by a synthetic fragment of human growth hormone (AOD9604) - study on fat oxidation and body weight changes in animal models.
4. Metabolic studies of a synthetic lipolytic domain (AOD9604) of the human growth hormone - paper on the metabolic significance of the lipolytic domain of hGH 177-191/AOD9604.

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.